CurrentCardio
Get Weekly

Topic · page 5 of 9

Cardio-oncology & other

Cardio-oncology, pericarditis, infective endocarditis, cardio-obstetrics, and cardiovascular topics outside the other eleven topics; a last resort whose size is reported per batch

Briefs 161–200 of 352 placed here, newest publication first

Briefs in Cardio-oncology & other

Newest publication first

  1. Eur Heart J

    Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study

    Cohort study

  2. Eur J Heart Fail

    Primary Cardioprotective Effect of Sacubitril/Valsartan in Breast Cancer Patients Receiving Adjuvant Therapy

    Randomised controlled trial

  3. Circulation

    Exercise Intolerance and Response to Training in Patients With Postacute Sequelae of SARS-CoV2 (Long COVID): A Scientific Statement From the American Heart Association

    Guideline or statement

  4. Eur Heart J

    Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement

    Guideline or statement

  5. Eur J Prev Cardiol

    External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients

    Diagnostic or prognostic study

  6. JACC CardioOncol

    Epigenetic Age Acceleration Mediates Treatment Effects on Cardiometabolic and Cardiovascular Risk in Childhood Cancer Survivors

    Cohort study

  7. Eur Heart J

    Immune checkpoint inhibitor-associated myocarditis: a novel risk score

    Cohort study

  8. Circulation

    Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study

    Cohort study

  9. Circulation

    Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance

    Randomised controlled trial

  10. JAMA Cardiol

    Accountable Care Organization Participation and Cardiovascular Care Quality

    Cohort study

  11. Eur Heart J

    Data sharing statements: impact of journal policies across clinical research disciplines

    Cross-sectional study

  12. Eur Heart J

    Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

    Guideline or statement

  13. Eur Heart J

    Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study

    Cohort study

  14. Eur J Heart Fail

    Cancer Therapy-related Cardiotoxicity is Associated with Distinct Alterations of the Myocardial Lipidome

    Mechanistic study

  15. JAMA Cardiol

    Trajectory of Cardiovascular Health Across Childhood and Adolescence

    Cohort study

  16. Eur J Prev Cardiol

    Human intravenous immunoglobulins for recurrent pericarditis: a multicentre cohort study

    Cohort study

  17. Circulation

    Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association

    Guideline or statement

  18. JACC CardioOncol

    Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal Cancer

    Cohort study

  19. Eur J Prev Cardiol

    Increased cancer incidence in patients with pre-existing heart failure: results from a French nationwide cohort study

    Cohort study

  20. JACC Cardiovasc Imaging

    Phenotypes of Myocardial Dysfunction on Serial Echocardiography and CMR in Women With Early-Stage Breast Cancer

    Secondary analysis

  21. Circulation

    Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association

    Guideline or statement

  22. JACC CardioOncol

    Immune Checkpoint Inhibitor–Related Myocarditis With or Without Concomitant Myopathy: Clinical Findings and Cardiovascular Outcomes

    Cohort study

  23. Europace

    Clinical profile and outcomes among patients with cardiac implantable electronic device presenting as isolated pocket infection, pocket-related infective endocarditis, or lead-related infective endocarditis

    Cohort study

  24. Circulation

    Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association

    Guideline or statement

  25. J Am Coll Cardiol

    Nonlinear Relation Between Cardiac Mortality and Excess Temperature in Heatwaves: Exposure Response in 2.39 Million Patients

    Research article

  26. Eur J Heart Fail

    Update on Preclinical Models of Cancer Therapy-Related Cardiac Dysfunction: Challenges and Perspectives. A Scientific Statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart

    Guideline or statement

  27. JACC CardioOncol

    Cardiac Effects of Modern Breast Radiation Therapy in Patients Receiving Systemic Cancer Therapy

    Cohort study

  28. JACC CardioOncol

    Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance

    Cohort study

  29. Circulation

    Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology

    Guideline or statement

  30. Circulation

    Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association

    Guideline or statement

  31. Nat Med

    Preeclampsia risk prediction from prenatal cell-free DNA screening

    Diagnostic or prognostic study

  32. Eur Heart J

    Hospitalization for cardiovascular disease in the year after delivery of twin pregnancies

    Cohort study

  33. Eur J Prev Cardiol

    Life’s Essential 8 and cardiovascular disease in women with a history of adverse pregnancy outcomes

    Cohort study

  34. JACC CardioOncol

    Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy

    Secondary analysis

  35. JACC CardioOncol

    Cardiovascular Considerations After Cancer Therapy: Gaps in Evidence and JACC: CardioOncology Expert Panel Recommendations

    Guideline or statement

  36. Circulation

    Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association

    Guideline or statement

  37. JACC CardioOncol

    Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients: Results From the Vienna CAT-BLED Study

    Cohort study

  38. JACC CardioOncol

    Effects of Systemic Anticancer Treatment on Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis

    Meta-analysis

  39. JACC CardioOncol

    Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy

    Cohort study

  40. Europace

    Impact of hospital lead extraction volume on management of cardiac implantable electronic device-associated infective endocarditis

    Cohort study

All 352 Briefs in ExploreShowing Briefs 161–200 of 352, newest first